StoneX Group
ALLR icon

StoneX Group’s Allarity Therapeutics ALLR Stock Holding History

StoneX Group’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$18.8K Buy
+17,388
New +$21.8K ﹤0.01% 1767

Other funds holding ALLR

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

StoneX Group's ALLR Position: Q3 2026 in Review

StoneX Group opened a new position in Allarity Therapeutics (ALLR) in Q3 2026: 17,388 shares worth $18.8K. The stake represents ﹤0.01% of the portfolio and ranks #1767 among its holdings.

3 funds tracked by Wall St. Rank hold ALLR as of Q3 2026.

  • StoneX Group held 17,388 shares of Allarity Therapeutics worth $18.8K as of Q3 2026.
  • Allarity Therapeutics was a new StoneX Group position in Q3 2026.
  • Allarity Therapeutics made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1767 holding.
  • 3 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.